Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors
- PMID: 18316578
- DOI: 10.1158/1078-0432.CCR-07-4126
Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors
Abstract
Purpose: Thrombospondin-1 (Tsp1), endostatin, and tumstatin are extracellular matrix-associated proteins that inhibit angiogenesis. We examined the mechanisms by which tumor cells may bypass the antiangiogenic effects of these endogenous regulators.
Experimental design: CT26 colon and RenCa renal carcinoma cells were stably transfected with Tsp1, endostatin, or tumstatin cDNA. Subcutaneous and metastatic tumor growth in syngeneic mice was analyzed. Expression of proangiogenic factors in resulting tumors was measured by quantitative real-time PCR. The combination of Tsp1 and vascular endothelial growth factor (VEGF) receptor-2 inhibition was also examined.
Results: There was significant suppression of angiogenesis in flank tumors and liver metastases formed from cells overexpressing Tsp1, endostatin, or tumstatin. However, all tumors ultimately escaped angiogenesis inhibition. The combination of all three angiogenesis inhibitors had no additive effect beyond overexpression of a single inhibitor. Using quantitative real-time PCR, we found that VEGF and platelet-derived growth factor (PDGF)-A levels were routinely up-regulated at least 5-fold in all CT26 tumors overexpressing any antiangiogenic protein, and there were variable increases in angiopoietin 2 (Ang2), basic fibroblast growth factor, and PDGF-B. In contrast, RenCa tumors, which have high baseline levels of VEGF and PDGF-B, relied on basic fibroblast growth factor, Ang1, and PDGF-A up-regulation to counteract Tsp1 overexpression. Growth of CT26 cells with Tsp1 overexpression was suppressed when anti-VEGFR-2 treatment was added.
Conclusions: Cancer cells with overexpression of three different endogenous angiogenesis inhibitor eventually escape angiogenesis inhibition by up-regulation of various proangiogenic factors. Tsp1, endostatin, and tumstatin may be functionally redundant in this system. These endogenous angiogenesis inhibitors are likely best used in combination with the blockade of proangiogenic pathways or with traditional chemotherapy or radiation therapy.
Similar articles
-
Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.Clin Cancer Res. 2008 Apr 1;14(7):2210-9. doi: 10.1158/1078-0432.CCR-07-1893. Clin Cancer Res. 2008. PMID: 18381963
-
Structural basis for the functions of endogenous angiogenesis inhibitors.Cold Spring Harb Symp Quant Biol. 2005;70:399-410. doi: 10.1101/sqb.2005.70.017. Cold Spring Harb Symp Quant Biol. 2005. PMID: 16869777 Review.
-
A comparison of antiangiogenic therapies for the prevention of liver metastases.J Surg Res. 2006 Mar;131(1):97-104. doi: 10.1016/j.jss.2005.09.008. Epub 2005 Oct 20. J Surg Res. 2006. PMID: 16242720
-
Tumstatin, the NC1 domain of alpha3 chain of type IV collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growth.Biochem Biophys Res Commun. 2005 Jul 29;333(2):292-8. doi: 10.1016/j.bbrc.2005.05.130. Biochem Biophys Res Commun. 2005. PMID: 15979458 Review.
-
Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.Cancer. 2000 Aug 1;89(3):488-99. Cancer. 2000. PMID: 10931447
Cited by
-
Targeting ADRB2 enhances sensitivity of non-small cell lung cancer to VEGFR2 tyrosine kinase inhibitors.Cell Death Discov. 2022 Jan 24;8(1):36. doi: 10.1038/s41420-022-00818-8. Cell Death Discov. 2022. PMID: 35075132 Free PMC article.
-
QPCT regulation by CTCF leads to sunitinib resistance in renal cell carcinoma by promoting angiogenesis.Int J Oncol. 2021 Jul;59(1):48. doi: 10.3892/ijo.2021.5228. Epub 2021 May 26. Int J Oncol. 2021. PMID: 34036385 Free PMC article.
-
Targeting of the COX-2/PGE2 axis enhances the antitumor activity of T7 peptide in vitro and in vivo.Drug Deliv. 2021 Dec;28(1):844-855. doi: 10.1080/10717544.2021.1914776. Drug Deliv. 2021. PMID: 33928829 Free PMC article.
-
Hypoxic tumor microenvironment: Implications for cancer therapy.Exp Biol Med (Maywood). 2020 Jul;245(13):1073-1086. doi: 10.1177/1535370220934038. Epub 2020 Jun 27. Exp Biol Med (Maywood). 2020. PMID: 32594767 Free PMC article. Review.
-
Role of Extracellular Matrix in Gastrointestinal Cancer-Associated Angiogenesis.Int J Mol Sci. 2020 May 23;21(10):3686. doi: 10.3390/ijms21103686. Int J Mol Sci. 2020. PMID: 32456248 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous